Drugs / Lactobacillus salivarius CECT5713
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04446572 | Oct 2018 → Nov 2019 | female infertility, habitual spontaneous abortion | Universidad Complutense de Madrid | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactobacillus salivarius CECT5713 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04446572 ↗ |
| Known as | L. salivarius CECT5713 | “The administration of L. salivarius CECT5713 (\~9 log10 CFU/day) for 6 months or until a diagnosis of pregnancy to women with reproductive failure resulted in an overall...” NCT04446572 ↗ |
| Modality | Other / unclassified | “freeze-dried probiotic” NCT04446572 ↗ |
| Route | Oral | “consumed (oral route)” NCT04446572 ↗ |